Thromb Haemost 2004; 91(01): 201-202
DOI: 10.1055/s-0037-1614258
Case Report
Schattauer GmbH

Eclampsia in a woman homozygous for the prothrombin G20210A mutation

Roger Klein
,
John Greg Howe
,
Urania Magriples
,
Peter McPhedran
Weitere Informationen

Publikationsverlauf

Received 29. Juni 2003

Accepted after resubmission 23. September 2003

Publikationsdatum:
09. Dezember 2017 (online)

 

 
  • References

  • 1 Kupferminc MJ, Eldor A, Steinman N. et al.. Increased Frequency of Genetic Thrombophilia in Women with Complications of Pregnancy. NEJM 1999; 340: 9-13.
  • 2 Kupferminc MJ, Fait G, Many A. et al.. Severe Preeclampsia and High Frequency of Genetic Thrombophilic Mutations. Obstet Gynecol 2000; 96: 45-9.
  • 3 Livingston J, Barton J, Park V. et al.. Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia. Am J Obstet Gynecol 2001; 185 (01) 153-7.
  • 4 Poort SR, Rosendaal FR, Reitsma PH. et al.. A Common Genetic Variation in the 3’-Untranslated Region of the Prothrombin Gene Is Associated With Elevated Plasma Prothrombin Levels and an Increase in Venous Thrombosis. Blood 1996; 88 (10) 3698-703.
  • 5 McGlennen R, Key N. Clinical and Laboratory Management of the Prothrombin G20210A Mutation. Arch Path Lab Med 2002; 126: 1319-98.
  • 6 Walker J. Pre-eclampsia. Lancet 2000; 356: 1260-5.
  • 7 Salafia C, Pezzullo J, Lopez-Zeno J. et al.. Placental pathologic features of preterm preeclampsia. Am J Obstet Gynecol 1995; 173: 1097-105.
  • 8 Mattar F, Sibai B. Eclampsia. VIII. Risk factors for maternal morbidity. Am J Obstet Gynecol 2000; 182: 307-12.